PillRx only · Tablet, Extended Release · Oral
Hyoscyamine Sulfate
Brands: Levbid · Hyoscyamine Sulfate
7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
7 active makers
7 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.530
Latest avg · Jul 22, 2026
-8%
Since Dec 17, 2025
7
Active US suppliers
29%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.8K
Rx · 2026 Q1
195K
Units dispensed
-8%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it7 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Pharma Packaging Solutions, LLC dba Tjoapack LLC | unknown | 1 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Laser Pharmaceuticals, LLC | unknown | 1 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Viatris Specialty LLC | unknown | 1 | SUPPLYING |
| Chartwell RX, LLC | unknown | 1 | SUPPLYING |
| Patrin Pharma, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.